LOGIN
Erythropoiesis-stimulating agents reduce allogeneic blood transfusion in TKA and THA
January 2014
Erythropoiesis-stimulating agents reduce allogeneic blood transfusion in TKA and THA
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
The Use of Preoperative Erythropoiesis-Stimulating Agents (ESAs) in Patients Who Underwent Knee or Hip Arthroplasty: A Meta-Analysis of Randomized Clinical Trials
J Arthroplasty. 2013 Oct;28(9):1463-72Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
26 randomized control trials comparing the use of erythropoiesis stimulating agents (ESAs) with any other intervention in patients who underwent hip or knee surgeries were pooled to determine the effectiveness of ESAs in reducing the need for allogeneic blood transfusions, increasing hemoglobin level, and, also, to determine the frequency of thromboembolic events in elective orthopaedic surgeries ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.